These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Deferoxamine for aluminum toxicity in dialysis patients. Hernandez P, Johnson CA. ANNA J; 1990 Jun; 17(3):224-8. PubMed ID: 2357118 [Abstract] [Full Text] [Related]
43. Recognition and management of aluminum intoxication in children. Tsuru N, Williams JL, Chan JC. Int J Pediatr Nephrol; 1987 Jun; 8(3):177-86. PubMed ID: 3323095 [Abstract] [Full Text] [Related]
44. The efficacy of various treatment modalities on aluminium associated bone disease. Ihle BU, Buchanan MR, Stevens B, Becker GJ, Kincaid-Smith P. Proc Eur Dial Transplant Assoc; 1983 Jun; 19():195-202. PubMed ID: 6348735 [Abstract] [Full Text] [Related]
45. Dialysis treatment in children with amyloidosis due to juvenile rheumatoid arthritis. Sieniawska M, Roszkowska-Blaim M, Wojciechowska B. Turk J Pediatr; 1996 Jun; 38(1):59-66. PubMed ID: 8819622 [Abstract] [Full Text] [Related]
46. [Amyloidosis of the dialysis patient]. van Ypersele de Strihou C. Bull Mem Acad R Med Belg; 1988 Jun; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074 [No Abstract] [Full Text] [Related]
50. The chemistry of desferrioxamine chelation for aluminum overload in renal dialysis patients. Day JP, Ackrill P. Ther Drug Monit; 1993 Dec; 15(6):598-601. PubMed ID: 8122301 [Abstract] [Full Text] [Related]
51. [Long term CaCO3 treatment of chronic hemodialysis patients--an attempt to prevent and treat aluminum osteopathy]. Matsubara M, Totsune K, Saito T, Yoshinaga K, Unagami H, Sato H. Nihon Jinzo Gakkai Shi; 1988 Nov; 30(11):1349-54. PubMed ID: 3236516 [No Abstract] [Full Text] [Related]
53. Nodular lesions on the tongue in the clinical presentation of dialysis-related amyloidosis. Simão dos Santos B, Rochael M, Araripe A, Diniz A, Werneck I, Andrade C. Int J Dermatol; 2013 Jun; 52(6):762-3. PubMed ID: 23679885 [No Abstract] [Full Text] [Related]